IDiyas

For the Inventor, By the Inventor

South Hadley, MA, United States of America

Craig G Bates

USPTO Granted Patents = 15

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • South Hadley, MA (US) (2006)
  • Pelham, NH (US) (2009 - 2022)

Company Filing History:

goldMedal12 out of 104 
 
Arqule, Inc.
 patents
silverMedal3 out of 1,552 
 
University of Massachusetts
 patents

Years Active: 2006-2022

Loading Chart...
15 patents (USPTO):Explore Patents
1. 11279679 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine (2022-03-22),
2. 11020398 - Amino-pyrrolopyrimidinone compounds and methods of use thereof (2021-06-01),
3. 10975087 - Solid forms of tetrahydropyranyl amino-pyrrolopyrimidinone compounds (2021-04-13),
4. 10766868 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine (2020-09-08),
5. 10717710 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2020-07-21),
6. 10227311 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2019-03-12),
7. 10093632 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine (2018-10-09),
8. 9981921 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2018-05-29),
9. 9834556 - Process of preparing 3-(3-(4-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-YL)pyridin-2-amine (2017-12-05),
10. 9834519 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine (2017-12-05),
11. 9464083 - Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-yl)pyridin-2-amine (2016-10-11),
12. 9422283 - Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound (2016-08-23),
13. 7473797 - Methods of 1,3-enyne preparation using copper (I) catalysts (2009-01-06),
14. 7473786 - Methods and systems for preparing fused heterocyclic compounds using copper(I) catalysts (2009-01-06),
15. 7112697 - Methods for formation of aryl-sulfur and aryl-selenium compounds using copper(I) catalysts (2006-09-26),

Title: **Inventor Spotlight: Craig G. Bates**

Introduction

Craig G. Bates is a prominent inventor based in South Hadley, MA (US). With an impressive portfolio of 15 patents, Bates has made significant contributions to the field of pharmaceuticals and chemical research. His innovative approaches have paved the way for advancements in medical treatments and drug formulations.

Latest Patents

Among his recent patents, Bates has developed novel methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine, which includes methods for preparing Compound A and its polymorphs, such as dihydrochloride salt. Furthermore, he has patented amino-pyrrolopyrimidinone compounds that modulate the activity of BTK, showcasing the potential of these compounds in treating diseases where BTK plays a crucial role. The pharmaceutical compositions designed by Bates mark a significant development in therapeutic applications.

Career Highlights

Throughout his career, Craig G. Bates has worked with notable organizations, including Arqule, Inc. and the University of Massachusetts. His roles in these institutions have allowed him to collaborate on cutting-edge research and push the boundaries of drug development.

Collaborations

Bates has had the opportunity to collaborate with esteemed colleagues such as David P. Reed and Jianmin Mao. These partnerships have contributed to the success of his research and the development of innovative solutions in the pharmaceutical landscape.

Conclusion

Craig G. Bates continues to leave a mark in the world of inventions and innovations. His work not only exemplifies the spirit of creativity but also plays a crucial role in advancing medical science through his patented inventions. The innovative methods and compounds he has developed reflect his dedication to improving health outcomes and demonstrate the impact of thoughtful research in society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…